Osteopontin is not critical for otoconia formation or balance function

JARO - Journal of the Association for Research in Otolaryngology

Volumn 9, Issue 2, 2008, Pages 191-201

  Zhao, Xing ^a   Jones, Sherri M ^b   Thoreson, Wallace B ^c   Lundberg, Yunxia Wang ^a  

^a BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Balance behaviors; Bone; Calcification; Vestibular evoked potentials

Indexed keywords

CALCIUM; CALCIUM CARBONATE; GLYCOPROTEIN; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MATRIX; CALCIFICATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CRYSTALLIZATION; EVOKED RESPONSE; HAIR CELL; INNER EAR; KNOCKOUT MOUSE; MASS; MECHANORECEPTOR; MOUSE; NONHUMAN; OTOLITH; PHENOTYPE; PRIORITY JOURNAL; SACCULUS; UTRICLE; VESTIBULE; WILD TYPE;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CRYSTALLIZATION; EVOKED POTENTIALS, SOMATOSENSORY; GRAVITY PERCEPTION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROSCOPY, ELECTRON, SCANNING; MOTOR SKILLS; MUSCULOSKELETAL EQUILIBRIUM; OSTEOPONTIN; OTOLITHIC MEMBRANE; SWIMMING;

EID: 44449136661     PISSN: 15253961     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10162-008-0117-z     Document Type: Article

References (59)

1. Balsamo G, Avallone B, Del GF, Trapani S, Marmo F. Calcification processes in the chick otoconia and calcium binding proteins: patterns of tetracycline incorporation and calbindin-D28K distribution. Hear Res. 148:1-8, 2000.
2. Berman JS, Serlin D, Li X, Whitley G, Hayes J, Rishikof DC, Ricupero DA, Liaw L, Goetschkes M, O'Regan AW. Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am. J. Physiol Lung Cell Mol. Physiol. 286:L1311-L1318, 2004.
3. Besson V, Nalesso V, Herpin A, Bizot JC, Messaddeq N, Romand R, Puech A, Blanquet V, Herault Y. Training and aging modulate the loss-of-balance phenotype observed in a new ENU-induced allele of Otopetrin1. Biol. Cell. 97:787-798, 2005.
4. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner. 22:147-159, 1993.
5. Bothe GW, Bolivar VJ, Vedder MJ, Geistfeld JG. Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comp. Med. 55:326-334, 2005.
6. Chakraborty G, Jain S, Behera R, Ahmed M, Sharma P, Kumar V, Kundu GC. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr. Mol. Med. 6:819-830, 2006.
7. Clarke KA, Still J. Gait analysis in the mouse. Physiol Behav. 66:723-729, 1999.
8. Dubois M, Strazielle C, Eyer J, Lalonde R. Sensorimotor functions in transgenic mice expressing the neurofilament/heavy-LacZ fusion protein on two genetic backgrounds. Neuroscience. 112:447-454, 2002.
9. El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17:463-474, 2006.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450, 1985.
11. Hamm RJ. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J. Neurotrauma. 18:1207-1216, 2001.
12. Hunter GK, Kyle CL, Goldberg HA. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem. J. 300(Pt 3):723-728, 1994.
13. Ichikawa H, Itota T, Nishitani Y, Torii Y, Inoue K, Sugimoto T. Osteopontin-immunoreactive primary sensory neurons in the rat spinal and trigeminal nervous systems. Brain Res. 863:276-281, 2000.
14. Ignatova EG, Thalmann I, Xu B, Ornitz DM, Thalmann R. Molecular mechanisms underlying ectopic otoconia-like particles in the endolymphatic sac of embryonic mice. Hear Res. 194:65-72, 2004.
15. Jones TA, Jones SM. Short latency compound action potentials from mammalian gravity receptor organs. Hear Res. 136:75-85, 1999.
16. Jones SM, Erway LC, Bergstrom RA, Schimenti JC, Jones TA. Vestibular responses to linear acceleration are absent in otoconia-deficient C57BL/6JEi-het mice. Hear Res. 135:56-60, 1999.
17. Jones SM, Subramanian G, Avniel W, Guo Y, Burkard RF, Jones TA. Stimulus and recording variables and their effects on mammalian vestibular evoked potentials. J. Neurosci. Methods. 118:23-31, 2002.
18. Jones SM, Erway LC, Johnson KR, Yu H, Jones TA. Gravity receptor function in mice with graded otoconial deficiencies. Hear Res. 191:34-40, 2004.
19. Ju WK, Kim KY, Cha JH, Kim IB, Lee MY, Oh SJ, Chung JW, Chun MH. Ganglion cells of the rat retina show osteopontin-like immunoreactivity. Brain Res. 852:217-220, 2000.
20. Klapdor K, Dulfer BG, Hammann A, Van der Staay FJ. A low-cost method to analyse footprint patterns. J. Neurosci. Methods. 75:49-54, 1997.
21. 2+-ATPase isoform 2. J. Biol. Chem. 273:18693-18696, 1998.
22. Laboux O, Ste-Marie LG, Glorieux FH, Nanci A. Quantitative immunogold labeling of bone sialoprotein and osteopontin in methylmethacrylate-embedded rat bone. J. Histochem. Cytochem. 51:61-67, 2003.
23. Lee MY, Choi JS, Lim SW, Cha JH, Chun MH, Chung JW. Expression of osteopontin mRNA in developing rat brainstem and cerebellum. Cell Tissue Res. 306:179-185, 2001.
24. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J. Clin. Invest. 101:1468-1478, 1998.
25. Lim DJ. Otoconia in health and disease. A review. Ann. Otol. Rhinol. Laryngol. 112(Suppl):17-24, 1984.
26. Lundberg YW, Zhao X, Yamoah EN. Assembly of the otoconia complex to the macular sensory epithelium of the vestibule. Brain Res. 1091:47-57, 2006.
27. Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C. Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol. Dis. 25:473-482, 2007.
28. Mark MP, Prince CW, Gay S, Austin RL, Butler WT. 44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rats: kidney and nervous tissues. Cell Tissue Res. 251:23-30, 1988.
29. Marsh BC, Kerr NC, Isles N, Denhardt DT, Wynick D. Osteopontin expression and function within the dorsal root ganglion. Neuroreport. 18:153-157, 2007.
30. Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, Doyle K, Lessov NS, Simon RP, Stenzel-Poore MP. Neuroprotection by osteopontin in stroke. J. Cereb. Blood Flow Metab. 25:217-225, 2005.
31. Murayama E, Takagi Y, Nagasawa H. Immunohistochemical localization of two otolith matrix proteins in the otolith and inner ear of the rainbow trout, Oncorhynchus mykiss: comparative aspects between the adult inner ear and embryonic otocysts. Histochem Cell Biol. 121:155-166, 2004.
32. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 56:571-580, 1999.
33. Ornitz DM, Bohne BA, Thalmann I, Harding GW, Thalmann R. Otoconial agenesis in tilted mutant mice. Hear Res. 122:60-70, 1998.
34. Pagano PJ, Haurani MJ. Vascular cell locomotion: osteopontin, NADPH oxidase, and matrix metalloproteinase-9. Circ. Res. 98:1453-1455, 2006.
35. Pote KG, Ross MD. Ultrastructural morphology and protein content of the internal organic material of rat otoconia. J. Ultrastruct. Mol. Struct. Res. 95:61-70, 1986.
36. Preston RE, Johnsson LG, Hill JH, Schacht J. Incorporation of radioactive calcium into otolithic membranes and middle ear ossicles of the gerbil. Acta Otolaryngol. 80:269-275, 1975.
37. Rampello L, Drago F. Nicergoline facilitates vestibular compensation in aged male rats with unilateral labyrinthectomy. Neurosci. Lett. 267:93-96, 1999.
38. rana-Chavez VE, Nanci A. High-resolution immunocytochemistry of noncollagenous matrix proteins in rat mandibles processed with microwave irradiation. J. Histochem. Cytochem. 49:1099-1109, 2001.
39. Ross MD, Peacor D, Johnsson LG, Allard LF. Observations on normal and degenerating human otoconia. Ann. Otol. Rhinol. Laryngol. 85:310-326, 1976.
40. Sajdel-Sulkowska EM, Nguon K, Sulkowski ZL, Rosen GD, Baxter MG. Purkinje cell loss accompanies motor impairment in rats developing at altered gravity. Neuroreport. 16:2037-2040, 2005.
41. Sakagami M. Role of osteopontin in the rodent inner ear as revealed by in situ hybridization. Med. Electron Microsc. 33:3-10, 2000.
42. Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain. 129:1426-1437, 2006.
43. Shapses SA, Cifuentes M, Spevak L, Chowdhury H, Brittingham J, Boskey AL, Denhardt DT. Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency. Calcif. Tissue Int. 73:86-92, 2003.
44. Shin SL, Cha JH, Chun MH, Chung JW, Lee MY. Expression of osteopontin mRNA in the adult rat brain. Neurosci. Lett. 273:73-76, 1999.
45. Sondag HN, de Jong HA, van MJ, Oosterveld WJ. Effects of sustained acceleration on the morphological properties of otoconia in hamsters. Acta Otolaryngol. 115:227-230, 1995.
46. Sondag HN, de Jong HA, van MJ, Willekens B, Oosterveld WJ. Otoconial alterations after embryonic development in hypergravity. Brain Res. Bull. 40:353-356, 1996.
47. Sondag HN, de Jong HA, van MJ, Oosterveld WJ. Behavioural changes in hamsters with otoconial malformations. Acta Otolaryngol. 118:86-89, 1998.
48. Sondag HN, de Jong HA, Oosterveld WJ. Behaviour of adult hamsters subjected to hypergravity. J. Vestib. Res. 9:13-18, 1999.
49. Takemura T, Sakagami M, Nakase T, Kubo T, Kitamura Y, Nomura S. Localization of osteopontin in the otoconial organs of adult rats. Hear Res. 79:99-104, 1994.
50. Trune DR, Lim DJ. The behavior and vestibular nuclear morphology of otoconia-deficient pallid mutant mice. J. Neurogenet. 1:53-69, 1983.
51. Verpy E, Leibovici M, Petit C. Characterization of otoconin-95, the major protein of murine otoconia, provides insights into the formation of these inner ear biominerals. Proc. Natl. Acad. Sci. U. S. A. 96:529-534, 1999.
52. Walton KD, Benavides L, Singh N, Hatoum N. Long-term effects of microgravity on the swimming behaviour of young rats. J. Physiol. 565:609-626, 2005.
53. Wang Y, Kowalski PE, Thalmann I, Ornitz DM, Mager DL, Thalmann R. Otoconin-90, the mammalian otoconial matrix protein, contains two domains of homology to secretory phospholipase A2. Proc. Natl. Acad. Sci. U. S. A. 95:15345-15350, 1998.
54. Wung JK, Perry G, Kowalski A, Harris PL, Bishop GM, Trivedi MA, Johnson SC, Smith MA, Denhardt DT, Atwood CS. Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Curr. Alzheimer Res. 4:67-72, 2007.
55. Ying HC, Hurle B, Wang Y, Bohne BA, Wuerffel MK, Ornitz DM. High-resolution mapping of tlt, a mouse mutant lacking otoconia. Mamm. Genome. 10:544-548, 1999.
56. Zhang DM, Takumida M, Harada Y. Uptake of tetracycline in otoconia of the guinea pig. Acta Otolaryngol. 116:732-736, 1996.
57. Zhao X, Jones SM, Yamoah EN, Lundberg YW. Oc90 deletion leads to imbalance but normal hearing: a comparison with other otoconia mutants. Neuroscience. 153:289-299, 2008.
58. Zhao X, Yang H, Yamoah EN, Lundberg YW. Gene targeting reveals the role of Oc90 as the essential organizer of the otoconial organic matrix. Dev. Biol. 304:508-524, 2007.
59. Zohar R, Zhu B, Liu P, Sodek J, McCulloch CA. Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am. J. Physiol Heart Circ. Physiol. 287:H1730-H1739, 2004.